跳至主要内容
临床试验/NCT04616417
NCT04616417已完成不适用

Investigational Oocyte Cryopreservation for Medical and Non Medical Indications

University of Illinois at Chicago2 个研究点 分布在 1 个国家目标入组 29 人开始时间: 2015年5月8日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
29
试验地点
2
主要终点
Structured Clinical Interview Completed After One Year After Oocyte Cryopreservation for Non-medical Reasons

研究概览

简要总结

This is a prospective study to assess the long term benefits and outcomes of the existing oocyte cryopreservation methods for fertility preservation in women with a potential medical or non medical risk of loss of fertility

详细描述

This is a prospective study to assess the long term benefits and outcomes of the existing oocyte cryopreservation methods for fertility preservation in women with a potential medical or non medical risk of loss of fertility. Women wishing to preserve their oocytes using cryopreservation will be informed of the risk and limitations of the procedures involved in ovarian hyperstimulation, oocyte recovery, cryopreservation and subsequent viability after warming. Women who consent to the procedure will undergo standard controlled ovarian hyperstimulation (COH) and oocyte retrieval procedures currently in use for IVF. Following harvest all eggs obtained will be evaluated for degree of fragmentation and maturation status. The oocytes will be cryopreserved using kits of media and devices currently approved for use in the vitrification of fertilized eggs and embryos, and the cryopreserved oocytes will be stored for future patient use in a long term storage facility in Minnesota (Reprotech Ltd.). Patients with stored oocytes will be contacted annually to determine the outcome of any oocyte warming procedures (oocyte thawing, fertilization and embryo transfer).

We will obtain a structured fertility focused quality of life questionnaire (FertiQol) and survey to assess one year after harvest the impact of the process. We will compare medical (cancer) patients to those patients undergoing oocyte cryopreservation for non-medical reasons

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Women aged >18 and < 40years
  • Women able to defer definitive cancer therapy for 21 to 30 days
  • Women diagnosed with cancer or any disease whose treatment or its progression may impair their reproductive potential (this would include but not be limited to cancer patients requiring treatment with chemotherapy or radiation, patients with rheumatologic diseases such as lupus, rheumatoid arthritis and ulcerative colitis and patients with genetic predisposition to cancers
  • Women undergoing standard In Vitro Fertilization to treat infertility who experience unforeseen events that halts the treatment cycle
  • Women seeking oocyte cryopreservation for non medical reasons, such as deferred childbearing
  • Women who are carriers of BRCA mutations predisposing them to cancer
  • Otherwise healthy females
  • Ability and willingness to comply with study protocol
  • Informed written consent, prior to any study-related procedure not part of normal care, with the understanding that the subject may withdraw consent at any time without prejudice to their future medical care

排除标准

  • Current pregnancy
  • Serum FSH > 10 mIU/ml for patients having egg freezing for a medical indication
  • Serum FSH > 10 mIU/ml for patients having egg freezing for social reasons
  • Women with psychological, psychiatric, or other conditions which prevent giving fully informed consent (Post Traumatic Stress Disorder, severe depression, bipolar disorder, schizophrenia, severe anxiety and inability to cope)
  • Patients with extensive disease whose therapy is deemed palliative by the medical oncologist

结局指标

主要结局

Structured Clinical Interview Completed After One Year After Oocyte Cryopreservation for Non-medical Reasons

时间窗: structured clinical interview completed after one year after oocyte cryopreservation

Study participants will be contacted on an annual basis using the "Investigational Oocyte Cropreservation Follow-up Call Script/structured interview" to determine any subsequent attempts to utilize the stored oocytes for the purpose of initiating a pregnancy, along with the outcome of the attempt. Only 9 patients completed this interview. There was not score assigned to this interview.

Structured Clinical Interview Completed After One Year After Oocyte Cryopreservation for Cancer Patients

时间窗: Structured Clinical Interview Completed After One Year After Oocyte Cryopreservation for cancer patients

study participants will be contacted on an annual basis using the "Investigational Oocyte Cropreservation Follow-up Call Script/structured interview" to determine any subsequent attempts to utilize the stored oocytes for the purpose of initiating a pregnancy, along with the outcome of the attempt. only 1 cancer patient completed this structured interview. There was not score assigned to this interview.

Fertility Quality of Life Questionnaire Completed After One Year After Oocyte Cryopreservation for Cancer Patients

时间窗: Fertility Quality of Life Questionnaire Completed After One Year After Oocyte Cryopreservation for cancer patients

We will obtain a structured fertility focused quality of life questionnaire (FertiQol) and survey to assess one year after harvest the impact of the process. We will compare cancer patients to those patients undergoing oocyte cryopreservation for non-medical reasons. FertiQol is scored based on the standards of the assessment tool in a quantitative manner. only one cancer patient completed this questionnaire.FertiQoL consists of 36 items that assess core (24 items) and treatment-related (10 items) quality of life as well as overall life and physical health (2 items). Higher scores indicated better outcomes and lower scores indicated worse outcomes on this questionnaire.

Fertility Quality of Life Questionnaire Completed After One Year After Oocyte Cryopreservation for Non-medical Reasons

时间窗: Fertility quality of life questionnaire completed after one year after oocyte cryopreservation

We will obtain a structured fertility focused quality of life questionnaire (FertiQol) and survey to assess one year after harvest the impact of the process. We will compare cancer patients to those patients undergoing oocyte cryopreservation for non-medical reasons. FertiQol is scored based on the standards of the assessment tool in a quantitative manner. Only 9 patients completed the this questionnaire. FertiQoL consists of 36 items that assess core (24 items) and treatment-related (10 items) quality of life as well as overall life and physical health (2 items). Higher scores indicated better outcomes and lower scores indicated worse outcomes on this questionnaire.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sana Salih

Principal Investigator

University of Illinois at Chicago

研究点 (2)

Loading locations...

相似试验